By KEN TERRY (This is the first in a series of excerpts from Terry’s new book, Physician-Led Healthcare Reform: a New Approach to Medicare for All, published by the American Association for Physician Leadership.) Even before COVID-19, healthcare reform seemed to be stuck between a rock and a hard place, but there is a rational… Read More: Physicians Should Lead on Healthcare Reform »
August 6, 2020 Posted By Categories Gary Schwitzer is the founder and publisher of HealthNewsReview. He has covered health care news almost exclusively since 1973. Here is his online bio. He tweets as @garyschwitzer or as @HealthNewsRevu. Getty Images On Tuesday, it was excitement over vaccine news in 12 monkeys. (Journalism example.) On Wednesday, it was excitement over… Read More: Crazy week of PR & news on studies should teach… »
FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More: FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with… »
Poor regulation of antibodies tests – that could indicate if someone has had coronavirus – could be putting the public at risk, doctors have warned. The Royal College of Pathologists has written to the health secretary, calling for rules to be tightened on kits sold direct to consumers. The letter warns they can “mislead the… Read More: Coronavirus antibodies tests ‘put public at risk’ »